Patents by Inventor Sanna ROSENGREN

Sanna ROSENGREN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING NRP2-ASSOCIATED DISEASES
    Publication number: 20230039401
    Abstract: Provided are therapies, including standalone and combination therapies, for treating neuropilin-2 (NRP2)-associated diseases and conditions, which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide.
    Type: Application
    Filed: June 15, 2022
    Publication date: February 9, 2023
    Inventors: Christoph BURKART, Kathleen M. OGILVIE, Suzanne PAZ, Sanna ROSENGREN, Kaustubh DATTA, Samikshan DUTTA
  • COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20220372151
    Abstract: Provided are methods of treatment of cancers with combinations of and compositions containing a soluble hyaluronidase, such as a polymer-modified soluble hyaluronidase, and an immune checkpoint inhibitor for treating cancers, including solid and non-solid tumors. The combinations and compositions also are provided.
    Type: Application
    Filed: June 27, 2022
    Publication date: November 24, 2022
    Inventors: Sanna ROSENGREN, H. Michael SHEPARD, Curtis B. THOMPSON
  • Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor
    Patent number: 11414489
    Abstract: Provided are methods of treatments with combinations or compositions containing a soluble hyaluronidase, such as a polymer-modified hyaluronidase, and an immune checkpoint inhibitor treating cancers, including solid and non-solid tumors. The combinations and compositions also are provided.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: August 16, 2022
    Assignee: Halozyme, Inc.
    Inventors: Sanna Rosengren, H. Michael Shepard, Curtis B. Thompson
  • COMPOSITIONS AND METHODS FOR TREATING NRP2-ASSOCIATED DISEASES
    Publication number: 20200085925
    Abstract: Provided are therapies, including standalone and combination therapies, for treating neuropilin-2 (NRP2)-associated diseases and conditions, which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide.
    Type: Application
    Filed: July 26, 2019
    Publication date: March 19, 2020
    Inventors: Christoph Burkart, Kathleen M. Ogilvie, Suzanne Paz, Sanna Rosengren, Kaustubh Datta, Samikshan Dutta
  • COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20180044419
    Abstract: Provided are methods of treatments with combinations or compositions containing a soluble hyaluronidase, such as a polymer-modified hyaluronidase, and an immune checkpoint inhibitor treating cancers, including solid and non-solid tumors. The combinations and compositions also are provided.
    Type: Application
    Filed: February 27, 2017
    Publication date: February 15, 2018
    Inventors: Sanna ROSENGREN, H. Michael Shepard, Curtis B. Thompson
  • COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20170218069
    Abstract: Provided are methods of treatments with combinations or compositions containing a soluble hyaluronidase, such as a polymer-modified hyaluronidase, and an immune checkpoint inhibitor treating cancers, including solid and non-solid tumors. The combinations and compositions also are provided.
    Type: Application
    Filed: February 27, 2017
    Publication date: August 3, 2017
    Inventors: Sanna ROSENGREN, H. Michael Shepard, Curtis B. Thompson